Literature DB >> 28477686

Correlation of vascular endothelial growth factor with magnetic resonance imaging in chronic subdural hematomas.

Fubin Li1, Cong Hua1, Yan Feng2, Hongyan Yuan3, Li Bie4.   

Abstract

BACKGROUND: Chronic subdural hematoma (CSDH) is an inflammatory angiogenic disease. It is believed that vascular endothelial growth factor (VEGF) plays an important role in pathological CSDH angiogenesis.
METHODS: In this study, magnetic resonance imaging (MRI) results were used to assign 115 primary CSDH patients to four MRI types. The four MRI types are described as follows: type 1 (T1-weighted low, T2-weighted low), type 2 (T1-weighted high, T2-weighted low), type 3 (T1-weighted mixed, T2-weighted mixed), and type 4 (T1-weighted low/high, T2-weighted high). The four MRI types were then correlated with CSDH stage and patient hematoma fluid and serum VEGH concentrations that were measured using an enzyme-linked immunosorbent assay (ELISA). Neurological status was assessed by Markwalder scoring at admission and six-month follow-up.
RESULTS: The mean VEGF concentration was significantly higher in CDSH hematoma fluid samples than in patient sera (p<0.01). In unilateral CSDH hematoma fluid samples, VEGF concentration was highest in type 1 (21,613.5±1473.3pg/ml), next highest in type 2 (18,071.8±1737.1pg/ml), lower in type 3, and lowest in type 4 patients (13,153.7±3854.4pg/ml, 7265.7±726.2pg/ml, respectively). High VEGF concentrations strongly correlated with MRI type (unilateral CSDH group r=0.838, bilateral CSDH group r=0.851, p<0.01). Moreover, higher hematoma fluid VEGF concentrations correlated with markedly higher recurrence in type 1 (3/19, 15.8%) vs. type 4 unilateral CSDH patients (1/27, 3.7%).
CONCLUSIONS: The present study reports a significant correlation between CSDH hematoma fluid VEGF concentration and MRI results. Therefore, MRI results could be used to predict hematoma fluid VEGF concentrations in CSDH patients.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chronic subdural hematoma; Magnetic resonance imaging; Recurrence; Vascular endothelial growth factor

Mesh:

Substances:

Year:  2017        PMID: 28477686     DOI: 10.1016/j.jns.2017.04.013

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

Review 1.  The pathophysiology of chronic subdural hematoma revisited: emphasis on aging processes as key factor.

Authors:  Ralf Weigel; Lothar Schilling; Joachim K Krauss
Journal:  Geroscience       Date:  2022-04-23       Impact factor: 7.581

2.  Adjunctive postoperative course of dexamethasone in chronic subdural hematoma: Effect on surgical outcome.

Authors:  Jibran Tariq; Sajid Nazir Bhatti
Journal:  Pak J Med Sci       Date:  2021 Nov-Dec       Impact factor: 1.088

3.  Dexamethasone enhances the efficacy of atorvastatin in inhibiting excessively inflammation-induced abnormal angiogenesis by regulating macrophages.

Authors:  Zhitao Gong; Daqiang Zhan; Meng Nie; Xiaochun Li; Chuang Gao; Xuanhui Liu; Tangtang Xiang; Jiangyuan Yuan; Weiwei Jiang; Jinhao Huang; Wei Quan; Dong Wang; Ye Tian; Hengjie Yuan; Jianning Zhang; Rongcai Jiang
Journal:  J Neuroinflammation       Date:  2021-09-15       Impact factor: 8.322

4.  MRI appearance of chronic subdural hematoma.

Authors:  Dimah Hasan; Omid Nikoubashman; Rastislav Pjontek; Andrea Stockero; Hussam Aldin Hamou; Martin Wiesmann
Journal:  Front Neurol       Date:  2022-08-08       Impact factor: 4.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.